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Adherence in Fellows’ Clinics
Judith Z. Goldﬁnger, MDL ow rates of adherence to medication and un-healthy lifestyle behaviors limit the efﬁcacyof primary and secondary prevention for car-
diovascular disease. Like many trainees, cardiology
fellows in our program predominantly see low-
income patients. However, when patients do not
take their medications, we should not assume that
cost is the sole reason, as other possible factors can
impact adherence. These other factors become espe-
cially important when they are related to a patient’s
knowledge, attitude, or culture. Instead of being
seen as barriers to care, they should be recognized
as an opportunity for the physician to engage with
the patient and strengthen the provider-patient
relationship.
Cost can contribute in overt ways, such as
lapsed insurance coverage, inability to pay for a
nonformulary drug, or a missing prior authoriza-
tion. However, ﬁnancial issues may have even more
insidious effects. For instance, to stretch a pre-
scription’s life just a little longer, patients may take a
drug less frequently than prescribed or cut a pill in
one-half.
Patients simply may forget to take their medica-
tions, and it can be difﬁcult to know when this is a
cause for concern. More than occasional forgetting
may point to an undiagnosed cognitive impairment,
which could be rectiﬁed with simple measures, like a
pillbox that indicates days of the week or the use of a
smartphone alarm as an electronic reminder. If these
are not adequate, a patient may require verbal re-
minders from a family member or from a home
attendant. Patients may be embarrassed to admit that
they need these kinds of reminders, and providers
often have to ask repeatedly, in different ways, to
draw them out.From the Icahn School of Medicine at Mount Sinai, New York, New York.Also, patients may decline to take their medica-
tions because of concerns that stem from “too little
information.” In my clinic panel, a woman with prior
renal cell carcinoma is afraid to take any medications
for her symptomatic atrial ﬁbrillation because she is
worried about losing her remaining renal function.
One male patient is concerned that the number of
milligrams is “too high” for his angiotensin-receptor
blocker compared with his beta-blocker. It is often
determined that these patients have low health lit-
eracy and could beneﬁt from education about their
medications. In addition, it is important to validate
their concerns and earn their trust, because this
empowers them to work with you to make better
health decisions and to achieve agreed-upon goals.
Conversely, there are the “too much information”
patients who also could beneﬁt from a frank conver-
sation with their physicians and validation of their
concerns. That was true of 1 male patient with coro-
nary artery disease and carotid disease who stopped
taking his statin because of media coverage about the
risk of incident diabetes with statins. Other patients
became concerned about media coverage related to
the risk of bleeding with oral anticoagulants, which
led some to suggest that they no longer wanted to
take this medication. These patients beneﬁt when
their physician spends time discussing their concerns
and provides relevant medical information to help
them make the best informed decisions about risks
and beneﬁts.
The risk-beneﬁt calculation may be different for
the physician than it is for the patient. The patient
weighs his or her understanding of the need for the
medication against the risk of taking the medication.
This understanding is affected by the physician’s
ability to explain, the patient’s ability to comprehend,
and what the patient hears from family, friends,
coworkers, the local pharmacist, and even Internet
search engines. Of these inﬂuencers, a patient spends
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627the least amount of time with his or her physician.
Understanding and working within this framework
can help physicians build a better rapport with their
patients or at least can create some common ground.
Other patients simply do not self-identify as
patients and do not want to join the club of “sick
people” who require regular use of medications for
chronic conditions. These patients inquire why they
cannot just take their antihypertensive medication
when they “feel” that their blood pressure is high. It
is easy to understand that you take an antipyretic
for fever, an anti-inﬂammatory for joint pain, or an
antibiotic for an infection. In these conditions, you
feel better when taking the medication, and then you
can stop taking it when it is done working. Medica-
tions for chronic conditions and cardiovascular risk
factors, like hypertension or diabetes, are quite the
opposite. Most patients cannot feel the symptoms of
their diseases. If not for the blood pressure cuff in our
ofﬁces or the laboratory results that we show them,
many would not be aware that they even have these
conditions. It may be helpful to spend time ex-
plaining the importance of risk reduction as well as
explaining how managing these conditions can pre-
vent or delay the development of cardiovascular
disease.
Finally, medications may simply make patients’
lives more difﬁcult. Furosemide may ameliorate
dyspnea, but it also may require an older person to
curtail his or her activities to remain near a bathroom.
If the physician only asks about dyspnea relief and
not about how the medications are affecting the
patient’s life and quality of life, he or she may not
ﬁnd this information.
All of these scenarios are layered over our patients’
socioeconomic and cultural backgrounds. The insti-
tution at which I train straddles the border between 1
of the wealthiest neighborhoods in New York City, theUpper East Side, and 1 of the poorest, East Harlem.
Our clinic patients largely come from East Harlem, a
predominantly black and Latino neighborhood that
has some of the highest rates of smoking, obesity,
sedentary lifestyle, and diabetes in New York City.
Adults in East Harlem have twice the poverty rate and
lower education rates compared with the rest of the
city (1). Economic burdens and limited education
likely contribute to decreased medication adherence,
but are not the full story; the high rates of cardio-
vascular risk factors and disease make the need for
adherence that much more urgent.
Patients may not be able to quote these statistics,
but they are more than aware of their own socioeco-
nomics and of the high rates of disease they see in
their families and communities. This knowledge can
be overwhelming, leaving some patients to feel
resigned or fatalistic. As cardiologists, we know that
some risk factors are not modiﬁable, but others are.
We also know that great gains can be achieved by
modifying risk factors and by adhering to medications
that have been proven effective for primary and sec-
ondary prevention of cardiovascular disease. We have
the ability to bring this knowledge to our patients.
In training programs, we are largely sheltered from
the economic burdens seen in clinical practice.
Instead, the fellows have a relatively luxurious 3-h
clinic session in which they see only 4 to 6 patients. If
ever there was a time to devote to patient barriers to
medication adherence, and to appropriate, personal-
ized education, this is it.
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